1. Kudoh, S. (1998). Erythromycin treatment in diffuse panbronchiolitis. Current Opinion in Pulmonary Medicine4, 116–21.
2. Kudoh, S. & Kimura, H. (1984). Clinical effect of low-dose long-term administration of macrolides on diffuse panbronchiolitis. Nihon Kyobu Shikkan Gakkai Zasshi254, Suppl., 254.
3. Kudoh, S., Azuma, A., Yamamoto, M. et al. (1998). Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. American Journal of Respiratory and Critical Care Medicine157, 1829–32.
4. Kudoh, S., Uetake, T., Hagiwara, K. et al. (1987). Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis. Nihon Kyobu Shikkan Gakkai Zasshi25, 632–42.
5. Yamamoto, M., Kondo, A., Tamura, M. et al. (1990). Long-term therapeutic effects of erythromycin and new quinolone antibacterial agents on diffuse panbronchiolitis. Nihon Kyobu Shikkan Gakkai Zasshi28, 1305–13.